AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 235 filers reported holding AXSOME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.57 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,927,832 | -28.0% | 41,892 | -24.7% | 0.00% | -60.0% |
Q2 2023 | $4,066,861 | +130793.5% | 55,619 | +8.4% | 0.01% | 0.0% |
Q1 2023 | $3,107 | -32.6% | 51,300 | -14.2% | 0.01% | -28.6% |
Q4 2022 | $4,613 | -99.8% | 59,820 | +3.2% | 0.01% | +75.0% |
Q3 2022 | $2,560,000 | – | 57,979 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |